Nelson Niviades Tejada Jr., Chief Merchandising Officer of 1-800-Flowers.com, Inc. (NASDAQ:FLWS), filed a statement of changes in beneficial ownership on November 9, 2026, disclosing a share withholding transaction dated November 5, 2026.
David Elliot Lazar filed a Schedule 13D with the SEC on November 9, 2026, disclosing the acquisition of preferred shares in Highway Holdings Ltd (NASDAQ:HIHO) totaling $7,000,000 in aggregate purchase price, following a triggering event dated November 4, 2026.
Eli Lilly and Company (NYSE:LLY) announced on November 9, 2026, positive Phase 3 results from the ATTAIN-OSA clinical program evaluating Foundayo (orforglipron) in adults with moderate-to-severe obstructive sleep apnea and obesity or overweight, with results presented at the American Heart Association Scientific Sessions 2026 …
Joseph C. Ventura, an officer of Humana Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 5,495 shares of Humana common stock through Goldman Sachs on the New York Stock Exchange.
Robin Energy Ltd. filed a Form 6-K with the U.S. Securities and Exchange Commission on November 9, 2026, disclosing that its Board of Directors has determined to effect a one-for-seventy five (1-for-75) reverse stock split of the company's common shares.
Morgan Stanley Finance LLC filed a free writing prospectus on November 9, 2026, for Principal at Risk Securities linked to NVIDIA Corporation common stock, with an automatic call feature and contingent coupon with memory, maturing November 15, 2027.
Morgan Stanley Finance LLC filed a free writing prospectus on November 9, 2026, for Market Linked Securities (Preliminary Pricing Supplement No. 19,955) linked to the lowest performing of three equity indexes, with an expected maturity of November 23, 2029.
Werewolf Therapeutics, Inc. filed a Form 8-K with the SEC on November 9, 2026, disclosing new clinical data from its Phase 1/1b trial of WTX-124 and its Phase 1b/2 trial of WTX-330 for the treatment of solid tumors.
Surgery Partners, Inc. filed a current report on November 9, 2026, disclosing that on November 8, 2026, it entered into Amendment No. 1 to its Agreement and Plan of Merger with Spyglass Topco, LLC, Spyglass Merger Subsidiary, Inc., and guarantor Bon Secours Mercy Health, …
James M. Langrock, Chief Financial Officer and SVP of 1 800 Flowers Com Inc, filed a Form 4 on November 9, 2026, disclosing a share withholding transaction on November 5, 2026, related to the vesting of restricted stock.